San Francisco—Successful trials of a drug designed to counter the deadly genetic glitches responsible for two forms of cancer portend a coming wave of novel therapies that will transform the way cancer is treated, said researchers gathered here for the annual meeting of the American Society of Clinical Oncology (ASCO).
The new therapies, the result of decades of basic research aimed at understanding the molecular biology of cancer, herald "the beginning of a sea change in how we practice cancer medicine," said ASCO President Larry Norton, MD, of Memorial Sloan-Kettering Cancer Center, New York.
Stephenson J. Researchers Optimistic About Sea Change in Cancer Treatment. JAMA. 2001;285(22):2841-2842. doi:10.1001/jama.285.22.2841